from2028 Activists Investors Trump Politicians Serenity Citrini Burry Semianalysis Swing Trade Arbitrage Search

$VRDN:NASDAQ · Viridian Therapeutics Inc - US

Sector: health

Conviction from: NASDAQ

52-week range: 13.1834.29

Thyroid eye disease biotech

2 tracked filer(s) hold this · 1 opened, 1 added, 0 trimmed in 30-JUN-2026

Aggregate 13FScore 72 — mean of 2 scored holder(s) · buyers (new/add) avg 72. Higher = the smart money in this name has the better track record.

Filer	13FScore	This quarter	Shares	Value	% of their book
Paul Tudor Jones / Tudor	63	New buy	62,184	$1,142,320	0.0%
Steve Cohen / Point72	80	Added +630%	2,356,208	$43,283,541	0.0%

Beyond 13F — activists, insiders, politicians & research

Activist 13D filings daily digest →

Filed	Form	Activist	% of class	Conviction
2026-05-13	SCHEDULE 13D/A	Fairmount Funds Management LLC	14.0%	High	filing

Insider open-market buys daily digest →

Filed	Insider	Role	Shares	Value
2026-05-13	Fairmount Funds Management LLC	director+10%-owner	1,176,470	$19,999,990	Form 4

Every tracked holder of this name, sorted new → added → flat → trimmed. Shares = reported 13F share count; Value as reported (a few managers file values in $thousands). Generated 2026-08-17.